Experience

Hybritech Inc. v. Abbott Laboratories

Hybritech Inc.

Abbott Laboratories

Represented Hybritech in associated interference proceedings relating to monoclonal antibody technology.

Hybritech Inc. v. Abbott Laboratories, 87-cv-00318, C.D. Cal.

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Office Invalidation Proceedings

Interferences

Related Industries

Life Sciences

Biotechnology

Related Experiences

Abbott Laboratories v. Sandoz Inc.

Abbott Laboratories

Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. 

Abbott Laboratories

Medtronic Vascular Inc. v. Abbott Vascular, Inc.

Abbott Vascular, Inc.

Bruce N. Saffran, M.D., Ph.D. v. Abbott Laboratories

Abbott Laboratories

Abbott Laboratories’ dominance in the coronary stent market is protected

Abbott Laboratories

Duchesnay, Inc. v. Actavis Laboratories Inc. and Mylan Pharmaceuticals, Inc.

Duchesnay

Universal Audio, Inc. v. Earbyte, Inc.

Universal Audio, Inc.

Commercial Copy Innovations, Inc. v. Mimaki USA, Inc. et al.

Mimaki USA, Inc.

Abbott Biotechnology Ltd. v. Centocor Ortho Biotech Inc. 

Abbott Biotechnology Ltd.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.